Next Article in Journal
The Distribution of Mobile Colistin-Resistant Genes, Carbapenemase-Encoding Genes, and Fluoroquinolone-Resistant Genes in Escherichia coli Isolated from Natural Water Sources in Upper Northeast Thailand
Next Article in Special Issue
Development and Implementation of a Mobile Application for Choosing Empirical Antimicrobial Therapy for Bacteremia, Pneumonia, Urinary Tract Infection, and Skin and Soft Tissue Infection among Hospitalized Patients
Previous Article in Journal
Resistance to Critical Important Antibacterials in Staphylococcus pseudintermedius Strains of Veterinary Origin
Previous Article in Special Issue
Changes in Antibiotic Prescribing Patterns in Danish General Practice during the COVID-19 Pandemic: A Register-Based Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Diagnosis and Antibiotic Treatment of Urinary Tract Infections in Danish General Practice: A Quality Assessment

by
Laura Trolle Saust
1,2,*,
Volkert Siersma
2,
Jesper Lykkegaard
3,
Lars Bjerrum
2 and
Malene Plejdrup Hansen
1,3
1
Center for General Practice, Department of Clinical Medicine, Aalborg University, 9220 Aalborg, Denmark
2
Section of General Practice and Research Unit for General Practice, Department of Public Health, University of Copenhagen, 1353 Copenhagen, Denmark
3
Audit Project Odense, Research Unit for General Practice, Department of Public Health, University of Southern Denmark, 5000 Odense, Denmark
*
Author to whom correspondence should be addressed.
Antibiotics 2022, 11(12), 1759; https://doi.org/10.3390/antibiotics11121759
Submission received: 14 November 2022 / Revised: 28 November 2022 / Accepted: 3 December 2022 / Published: 5 December 2022
(This article belongs to the Special Issue Antimicrobial Stewardship and Prescribing Practice)

Abstract

:
Rational antibiotic treatment of urinary tract infections (UTI) is important. To improve the quality of antibiotic treatment of UTI, it is essential to obtain insight into diagnostic approaches and prescribing patterns in general practice. The aim of this study was to investigate the quality of diagnostics and treatment of UTI in general practice by means of quality indicators (QIs). QIs provide a quantitative measure of quality and are defined by a numerator (the number of patients receiving a specific investigation or treatment) and a denominator (the number of patients included in the quality assessment). For adult patients with suspected UTI, practices registered the following: age, sex, risk factors, symptoms and signs, examinations, diagnosis and treatment. The levels of the QIs were compared with their corresponding standards. Half of the patients diagnosed with lower UTI or pyelonephritis fulfilled the diagnostic criteria for UTI: characteristic UTI symptoms and clear signs of bacteriuria, respectively. Urinalysis was performed for nearly all patients, including patients without characteristic symptoms of UTI. One-fourth of the patients with suspected lower UTI were treated with antibiotics despite no urinalysis and nearly half received antibiotics despite an inconclusive dipstick test. Pivmecillam was the preferred antibiotic. The findings of this study indicate that there is room for improvement in the management of UTI in Danish general practice.

1. Introduction

Antibiotic resistance has a major impact on human health worldwide and is mainly driven by the use of antibiotics [1]. About 80% of the total human consumption of antibiotics is prescribed in general practice [2]. In Denmark, general practice is organised into small units. A general practice is most often owned by one or several general practitioners (GPs), and staff members—such as secretaries and nurses—are employed. The GPs act as gatekeepers and first-line providers, meaning that a referral from a GP is required for most specialists and always for hospital treatment (except acute admissions) [3].
The prevalence of urinary tract infections (UTI) varies depending on different risk factors such as age and gender. In Denmark, between 5% and 8% of women aged 40–45 years have UTI on a given day [4]. One of the main indications for antibiotic prescriptions in general practice is UTI, particularly for women and elderly patients [5]. In Denmark, total antibiotic consumption has decreased over the past decade [5]. Still, a high number of antibiotic prescriptions are issued in the elderly population, including a relatively high prescription rate of quinolones [6,7,8]. These findings urge interventions to improve the quality of antibiotic use for UTI. Most research focuses on the amount and type of antibiotics prescribed, with very little on the diagnostic process and what lies behind the decision to prescribe antibiotics [9,10,11]. In Danish general practice, not only GPs but also practice staff attend to patients with suspected UTI, although any antibiotics prescribed have to be approved by a GP. Urinalyses, such as microscopy, dipstick, culture and susceptibility testing, are widely performed in general practice. Results are available while patients are still in the consultation (microscopy and dipstick) or within 24 h (culture and susceptibility testing) [12]. Importantly, it may take up to three days to receive the results when urine samples are sent for analysis at the hospital’s microbiological laboratory. Both patients with lower and upper UTI are treated in general practice. In Danish guidelines, uncomplicated lower UTI are defined as UTI in an adult, in non-pregnant woman, and are regardless of age [13,14,15]. Antibiotic treatments for UTI are mostly prescribed at the index consultation, where the patient presents with the UTI for the first time [16]. To improve the quality of care for patients suspected of having UTI it is important to obtain insight into the quality of current diagnostic approaches and prescribing patterns. For this purpose, relevant quality indicators (QIs) can be applied. QIs are measurable parameters that survey potential quality problems [17]. QIs are an important stimulus in the improvement of antibiotic prescribing [18,19]. Recently, a set of indicators comprising the diagnostic process and antibiotic treatment of patients with suspected UTI was developed for use in general practice [20]. These indicators are based on national guidelines and are validated by a panel of experts. By means of the newly developed QIs, the aim of this study was to investigate the present quality of the diagnostic process and antibiotic treatment of UTI in Danish general practice.

2. Results

A total of 101 out of the 970 invited practices participated in the study (10.4% response rate). A total of 3076 consultations with patients suspected of having UTI were registered.
At the index consultation, 1514 patients were labelled as “unresolved” (continued suspicion of UTI, but, for example, awaiting a urine culture result). A total of 1263 patients were diagnosed with lower UTI and 16 patients with upper UTI (pyelonephritis). The remaining 219 patients were labelled as “not UTI”, and 64 had a missing diagnosis.
Table 1 shows levels and standards for QIs focusing on the diagnostic process.
Two out of the eleven indicators were within the standard. Nearly all the patients suspected of having UTI who did not have any UTI symptoms (dysuria, frequency, urgency, new-onset incontinence, suprapubic pain or flank pain) nor any systemic signs of infection (fever, shivering or systemically unwell), nevertheless, had a urinalysis performed (urinary dipstick, microscopy and/or urine culture) (QI1). Almost 90% of patients diagnosed with lower UTI had at least one lower urinary tract symptom (QI3). Nonetheless, only about half of the patients diagnosed with either lower UTI or pyelonephritis had UTI symptoms and clear signs of bacteriuria (dipstick positive nitrite and leucocytes and/or positive microscopy) (QI2 and QI5). Most patients diagnosed with complicated lower UTI or pyelonephritis had a urine culture and susceptibility test performed (QI4 and QI6).
Table 2 shows the levels and standards for QIs focusing on the treatment decision.
One out of the six QIs was within the standard. A total of 26% of patients with suspected lower UTI were treated with antibiotics despite the lack of a urinalysis (QI12). Among patients with UTI symptom(s), 11% of those with a negative urinary dipstick (negative leucocytes, negative nitrite) and nearly half of those with an inconclusive urinary dipstick (positive leucocytes, negative nitrite) were treated with antibiotics (QI13 and QI14).
Table 3 shows the levels and standards for QIs focusing on the choice of antibiotics.
Four out of six QIs were within the standard. A total of 83% of patients without a penicillin allergy treated with antibiotics were prescribed pivmecillinam (QI19). Pivmecillinam was also the most frequently prescribed antibiotic for pregnant women and patients diagnosed with pyelonephritis (QI21 and QI24). Very few patients were treated with ciprofloxacin (QI20 and QI23).

3. Discussion

3.1. Main Findings

According to the diagnostic process, nearly all patients had a urinalysis performed at the index consultation. However, inappropriately, this also included most patients presenting to general practice with no UTI symptoms (QI1). Only about half of the patients who were diagnosed with lower UTI or pyelonephritis fulfilled the two diagnostic criteria: having the characteristic UTI symptoms and a urinalysis indicating bacteriuria, respectively (QI2 and QI5). Regarding the treatment decision, one-fourth of patients with suspected lower UTI were treated with antibiotics despite the lack of a urinalysis (QI12). Nearly half of the patients with lower urinary tract symptom(s) were treated with antibiotics even though they had an inconclusive urinary dipstick (positive leucocytes, negative nitrite) (QI14). The majority of patients treated with antibiotics were prescribed pivmecillinam, and very few were prescribed ciprofloxacin (QI19 and QI20).

3.2. Strengths and Limitations

To our knowledge, this is the first study to investigate the quality of the diagnostic process and antibiotic treatment of UTI in general practice by means of validated Qis. Another important strength is the large number of patients and practices included in the study. The data collection process was simple and fast, thus securing the continuous inclusion of patients.
The healthcare professionals who volunteered to register their consultations may have been particularly interested in the management of patients with UTI and may have been more likely to follow guidelines compared to non-participants. Hence, quality may look better in the present data than in Danish general practice in general, which merely underlines the deviations from quality standards found in the present study.
A total of 23 out of the 24 validated QIs were applicable to the data collected using the registration chart. As information about changing the catheter before the start of antibiotic treatment was not available in the APO registration chart, QI17 could not be applied.
The construction of two of the indicators might not sufficiently reflect the widespread use of microscopy in Danish general practice (QI13 and QI14). Microscopic verification of uropathogenic bacteria in a patient with urinary tract symptoms may have led to antibiotic prescribing in spite of a negative dipstick. However, when removing patients with a positive microscopy from the two indicators above (QI13 and QI14), we still found a substantial number of patients treated with antibiotics in spite of a negative or inconclusive dipstick.
Only data from the index consultation were collected. Consequently, we were not able to investigate the quality of any antibiotic treatment prescribed after receiving the results of urine culture and/or susceptibility testing. However, most antibiotics are prescribed on day one [16]. Thus, insight restricted to the care at day one provides an adequate basis for assessing the most central elements in the quality of care for patients with suspected UTI.

3.3. Comparisons with Other Studies

3.3.1. QIs Focusing on the Diagnostic Process

A total of 476 patients (15.5%) included in the study had none of the genitourinary symptoms attributable to UTI, nor any systemic signs of infection. Nevertheless, nearly all of these patients had a urinalysis performed with either a dipstick, microscopy and/or urine culture (QI1). Similar results were obtained in another recent Danish study, which found that the majority of patients without UTI symptoms had a urine culture performed [21]. According to the Danish guidelines it is not recommended to perform a urinalysis in patients with the absence of signs and symptoms of UTI [13,14,15,22,23]. Bacteriuria might be misinterpreted as UTI, leading to overprescribing of antibiotics in asymptomatic patients. Despite clear evidence against the treatment of asymptomatic bacteriuria [24], this condition continues to be a common reason for antibiotic treatment [25]. Unnecessary urinalyses promote inappropriate antibiotic prescribing.
UTI are defined by the presence of UTI symptoms in combination with a significant amount of uropathogenic bacteria in the urine [13].
We found that only half of the patients fulfilled the two diagnostic criteria for having UTI: the presence of UTI symptoms and clear signs of bacteriuria (dipstick showing positive nitrite and positive leucocytes and/or positive microscopy) when diagnosed with lower UTI (QI2). Similar results for patients diagnosed with pyelonephritis were found (QI5), indicating a certain degree of mislabelling of both upper and lower UTI.

3.3.2. QIs Focusing on the Treatment Decision

Time pressure, consultation over the phone, and patient treatment expectations are possible explanations for antibiotic prescribing without the result of a preceding urinalysis. These factors are identified as some of the barriers to appropriate antibiotic prescribing [26]. Only about 50% of patients presenting to general practice with urinary tract symptoms actually have UTI [14]. Consequently, treatment based on symptoms alone might lead to the overuse of antibiotics. One of the three main recommendations in the Danish guideline is “no antibiotics without urinalysis” [14]. In this present study, we found that 26% of patients with suspected lower UTI were treated with antibiotics without having a urinalysis performed (QI12).
We found that 11% of patients with lower urinary tract symptoms were treated with antibiotics despite having a negative dipstick (leucocyte and nitrite) (QI13). The probability of having UTI for these patients is low [14,27].
A total of 42% of the patients with the symptom(s) of lower UTI who had an inconclusive urinary dipstick (positive leucocytes and negative nitrite) were treated with antibiotics (QI14). Little et al. found a 75% probability of having UTI when only leucocytes are positive on the dipstick [27]. Holm suggests that the probability is even lower in Denmark [28]. Danish guidelines recommend not initiating antibiotic treatment empirically for patients with an inconclusive urinary dipstick, but waiting for the result of a urine culture [13,14,23].
Nearly all patients diagnosed with pyelonephritis were treated with antibiotics (patients referred to hospitals were excluded) (QI15). This indicates that when GPs suspect “pyelonephritis” they prescribe antibiotics. However, only half of the patients diagnosed with pyelonephritis presented typical symptoms of pyelonephritis and bacteriuria (QI5). This indicates mislabelling leading to the overprescribing of antibiotics. Nevertheless, the underprescribing of antibiotics for pyelonephritis may also take place. Less than half of catheter users with the symptom(s) of pyelonephritis were treated with antibiotics (QI16). In line with our findings, Sommer-Larsen et al. showed that in a nursing home, only about one-third of patients with symptoms indicative of pyelonephritis received antibiotics [21].

3.3.3. QIs Focusing on the Choice of Antibiotics

A total of 83% of patients with suspected lower UTI and no penicillin allergy treated with antibiotics were treated with a first-choice antibiotic (pivmecillinam) (QI19). In line with our findings, a study from 2019 describing the prescriptions for UTI in general practice in Denmark found that pivmecillinam was the most common antibiotic prescribed for lower UTI (45.8% of the prescriptions) [6]. Interestingly, the percentage of patients treated with a first-choice antibiotic for UTI according to national guidelines varies quite a lot in other countries: Belgium (22%), the Netherlands (73%) and Sweden (87%) [29].
We found a very small proportion (1%) of quinolones prescribed for lower UTI (QI20). In comparison with other countries, higher quinolone prescription rates are seen: 22% in Belgium, 7% in the Netherlands, 3% in Sweden and 37% in Switzerland [29,30].

4. Materials and Methods

This study is part of a larger quality improvement project originating from Audit Project Odense (APO) with the overall aim of improving the quality of the diagnosis and treatment of UTI in general practice [31,32]. All general practices in the Capital and Southern Regions of Denmark were invited to participate in the project. Throughout a 30-day registration period in January to March 2020 (Capital Region) and October to November 2020 (Region of Southern Denmark), healthcare professionals registered all patients aged ≥18 years with suspected UTI consulting general practice. The suspicion of UTI could have different possible origins, either from the patient, the GP, the general practice staff, a home care nurse and/or a relative. Only information concerning the first day of contact with the general practice (index consultation) was included.
The registrations were performed on A4-size paper registration charts. For each patient, information about the patient’s age, sex, risk factors, symptoms and signs, examinations carried out, diagnosis given and actions made (e.g., hospitalisation, antibiotics prescribed) were recorded in the registration chart (Supplementary Material File S1).

4.1. Quality Indicators

A set of 23 out of 24 validated QIs for the management of patients aged ≥18 years with suspected UTI was applied to the APO dataset [20]. An indicator provides a quantitative measure of quality and is defined by a numerator (the number of patients receiving a specific investigation or treatment) and a denominator (the number of patients included in the quality assessment). Each QI was developed with an accompanying standard to encompass the optimal performance addressed by that indicator. The indicators were divided into three quality domains, focusing on either the diagnostic process, the treatment decision or the choice of antibiotics prescribed. The indicators comprise lower UTI (complicated and uncomplicated), pyelonephritis and some concern only specific patient groups, such as catheter users and pregnant women.

4.2. Statistical Analysis

Data from the registration chart were used to calculate the levels of the QIs. The proportion of relevant observations fulfilling each of the 23 QIs was calculated as a percentage and compared with its corresponding standard. A 95% confidence interval (95%CI) for the corresponding odds was estimated using the method of generalised estimating equations (GEE) to adjust for correlation within practices; these were transformed back with the logit formula to obtain the 95%CI for the percentages. The data were analysed using SAS 9.4.

5. Conclusions

This study presents an analysis of the quality of care for patients suspected of having UTI in Danish general practice. Urinalyses, such as dipstick, microscopy, culture and susceptibility testing, were found to be used excessively. The findings also indicate antibiotic overuse. However, high adherence to guidelines was found regarding the choice of antibiotic prescribed. Importantly, antibiotic underprescribing was also implied in some cases.
The results of the study are based on the application of a set of QIs. Though it is important to keep in mind that QIs are used to generate reflection and debate about the quality of care rather than a definitive judgment of quality.
The QIs applied in this study represent a useful tool for evaluating and comparing the quality of the diagnosis and antibiotic treatment of patients presenting with suspected UTI.
The findings of the study can be used as a basis for future interventions to improve the quality of management of patients with suspected UTI. Further research should focus on the application of the indicators on a larger scale as part of a system-wide quality investigation program accessible to all general practices in Denmark. The application of the indicators to general practices in, for example, the Nordic countries may also offer an important opportunity to improve care.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/antibiotics11121759/s1, File S1: Suspected urinary tract infections in patients ≥ 18 years.

Author Contributions

Conceptualisation, J.L., M.P.H., L.T.S. and L.B.; methodology, J.L. and L.T.S.; software, V.S.; formal analysis, V.S. and L.T.S.; data curation, V.S.; writing—original draft preparation, L.T.S.; writing—review and editing, L.T.S., M.P.H., L.B., J.L. and V.S.; supervision, M.P.H. and L.B.; project administration, L.T.S.; funding acquisition, L.B. and J.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Danish Research Foundation for General Practice and Kvalitets- og Efteruddannelsesudvalget (KEU) in the Capital Region of Denmark and the Region of Southern Denmark.

Institutional Review Board Statement

All healthcare participants consented to the study. Only anonymised patient data were obtained. The project is registered at the Research Unit for General Practice in Aalborg (ID:251-3).

Informed Consent Statement

Patient consent was waived due to only anonymised patient data were obtained.

Data Availability Statement

The data presented in this study are not publicly available due to privacy restrictions.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. Leung, E.; Weil, D.E.; Raviglione, M.; Nakatani, H. The WHO policy package to combat antimicrobial resistance. Bull. World Health Organ. 2011, 89, 390–392. [Google Scholar] [CrossRef] [PubMed]
  2. Saust, L.T.; Bjerrum, L.; Siersma, V.; Arpi, M.; Hansen, M.P. Quality assessment in general practice: Diagnosis and antibiotic treatment of acute respiratory tract infections. Scand. J. Prim. Health Care 2018, 36, 372–379. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Pedersen, K.M.; Andersen, J.S.; Snødergaard, J. General practice and primary health care in Denmark. J. Am. Board Fam. Med. 2012, 25, 34–38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Jensen, C.S.; Walter, S. Urinvejsinfektioner—Forekomst, årsager og forebyggelse. [Urinary tract infections—Incidence, causes and prevention]. Ugeskr. Laeger. 2007, 169, 4265–4268. [Google Scholar] [PubMed]
  5. Danmap 2019—Use of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Bacteria from Food Animals, Food and Humans in DENMARK. 2020. Available online: www.danmap.org (accessed on 3 November 2022).
  6. Holm, A.; Cordoba, G.; Aabenhus, R. Prescription of antibiotics for urinary tract infection in general practice in Denmark. Scand. J. Prim. Health Care 2019, 37, 83–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Aabenhus, R.; Siersma, V.; Hansen, M.P.; Bjerrum, L. Antibiotic prescribing in Danish general practice 2004–2013. J. Antimicrob. Chemother. 2016, 71, 2286–2294. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Medstat. Available online: https://medstat.dk/ (accessed on 3 November 2022).
  9. Colliers, A.; Adriaenssens, N.; Anthierens, S.; Bartholomeeusen, S.; Philips, H.; Remmen, R.; Coenen, S. Antibiotic prescribing quality in out-of-hours primary care and critical appraisal of disease-specific quality indicators. Antibiotics 2019, 8, 79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Williams, M.R.; Greene, G.; Naik, G.; Hughes, K.; Butler, C.C. Antibiotic prescribing quality for children in primary care: An observational study. Br. J. Gen. Pract. 2018, 68, e90–e96. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  11. Adriaenssens, N.; Bartholomeeusen, S.; Ryckebosch, P.; Coenen, S. Quality of antibiotic prescription during office hours and out-of-hours in Flemish primary care, using European quality indicators. Eur. J. Gen. Pract. 2014, 20, 114–120. [Google Scholar] [CrossRef] [PubMed]
  12. Hoejbjerg, T.; Paulsen, K. Digital Håndbog i Mikrobiologisk Analyse. [Digital Manual of Microbiological Analysis]. Available online: http://mikrobiologiskanalyse.dk/index.html?url=content.xml (accessed on 3 November 2022).
  13. Lægehåndbogen. Cystitis Ukompliceret [Uncomplicated Lower Urinary Tract Infection]. 2019. Available online: https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/nyrer-og-urinveje/tilstande-og-sygdomme/infektioner/cystit-ukompliceret/ (accessed on 3 November 2022).
  14. FAQta-Ark om Urinvejsinfektioner i Almen Praksis [Fact Sheet on Urinary Tract Infections in General Practice]. 2021. Available online: https://vejledninger.dsam.dk/media/files/17/uvi_faqta-ark.pdf (accessed on 3 November 2022).
  15. Medicinrådets Behandlingsvejledning Vedrørende Urinvejsinfektioner [The Danish Medicine Agency’s Treatment Guidelines Regarding Urinary Tract Infections]. 2019. Available online: https://medicinraadet.dk/anbefalinger-og-vejledninger/behandlingsvejledninger/urinvejsinfektioner-uvi (accessed on 3 November 2022).
  16. Pujades-Rodriguez, M.; West, R.M.; Wilcox, M.H.; Sandoe, J. Lower Urinary Tract Infections: Management, Outcomes and Risk Factors for Antibiotic Re-prescription in Primary Care. EClinicalMedicine 2019, 14, 23–31. [Google Scholar] [CrossRef] [PubMed]
  17. Marshall, M.; Campbell, S.; Hacker, J.; Roland, M. Quality Indicators for General Practice: A Practical Guide for Health Professionals and Managers; Royal Society of Medicine Press Limited: London, UK, 2002; pp. 1–186. [Google Scholar]
  18. Adriaenssens, N.; Coenen, S.; Versporten, A.; Muller, A.; Vankerckhoven, V.; Goossens, H. European Surveillance of Antimicrobial Consumption (ESAC): Quality appraisal of antibiotic use in Europe. J. Antimicrob. Chemother. 2011, 66, vi71–vi77. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  19. Urbiztondo, I.; de Oliveira, S.M.; Hernández-Flores, N.; Caballero, L.; Suarez, M.A.; Bjerrum, L.; Cordoba, G. General practitioners’ views on the acceptability and applicability of using quality indicators as an intervention to reduce unnecessary prescription of antibiotics in four South American countries. Antibiotics 2018, 7, 57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Saust, L.T.; Bjerrum, L.; Hansen, M.P.; Siersma, V. Development of quality indicators for the diagnosis and treatment of urinary tract infections in general practice: A RAND appropriateness method. in submission.
  21. Sommer-Larsen, S.D.; Arnold, S.H.; Holm, A.; Olesen, J.A.; Cordoba, G. Quality of the diagnostic process, treatment decision, and predictors for antibiotic use in general practice for nursing home residents with suspected urinary tract infection. Antibiotics 2021, 10, 316. [Google Scholar] [CrossRef] [PubMed]
  22. Lægehåndbogen. Pyelonefritis [Pyelonephritis] 2019. Available online: https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/nyrer-og-urinveje/tilstande-og-sygdomme/infektioner/pyelonefritis/ (accessed on 3 November 2022).
  23. Lægehåndbogen. Cystitis Kompliceret [Complicated Lower Urinary Tract Infection]. 2019. Available online: https://www.sundhed.dk/sundhedsfaglig/laegehaandbogen/nyrer-og-urinveje/tilstande-og-sygdomme/infektioner/cystitis-kompliceret/ (accessed on 3 November 2022).
  24. Nicolle, L.E. The paradigm shift to non-treatment of asymptomatic bacteriuria. Pathogens 2016, 5, 38. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Petty, L.A.; Vaughn, V.M.; Flanders, S.A.; Malani, A.N.; Conlon, A.; Kaye, K.S.; Thyagarajan, R.; Osterholzer, D.; Nielsen, D.; Eschenauer, G.A.; et al. Risk Factors and Outcomes Associated with Treatment of Asymptomatic Bacteriuria in Hospitalized Patients. JAMA Intern. Med. 2019, 179, 1519–1527. [Google Scholar] [CrossRef] [PubMed]
  26. Lecky, D.M.; Howdle, J.; Butler, C.C.; McNulty, C.A.M. Optimising management of UTIs in primary care: A qualitative study of patient and GP perspectives to inform the development of an evidence-based, shared decision-making resource. Cancer Prev. Res. 2020, 13, E330–E338. [Google Scholar] [CrossRef] [PubMed]
  27. Little, P.; Turner, S.; Rumsby, K.; Warner, G.; Moore, M.; Lowes, J.A.; Smith, H.; Hawke, C.; Mullee, M. Developing clinical rules to predict urinary tract infection in primary care settings: Sensitivity and specificity of near patient tests (dipsticks) and clinical scores. Br. J. Gen. Pract. 2006, 56, 606–612. [Google Scholar] [PubMed]
  28. Holm, A. Diagnosing Urinary Tract Infection in General Practice. Ph.D. Thesis, Graduate School of the Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark, 21 April 2017. [Google Scholar]
  29. Tyrstrup, M.; van der Velden, A.; Engstrom, S.; Goderis, G.; Molstad, S.; Verheij, T.; Coenen, S.; Adriaenssens, N. Antibiotic prescribing in relation to diagnoses and consultation rates in Belgium, the Netherlands and Sweden: Use of European quality indicators. Scand. J. Prim. Health Care 2017, 35, 10–18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Glinz, D.; Reyes, S.L.; Saccilotto, R.; Widmer, A.F.; Zeller, A.; Bucher, H.C.; Hemkens, L.G. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: A nationwide survey. J. Antimicrob. Chemother. 2017, 72, 3205–3212. [Google Scholar] [CrossRef] [PubMed]
  31. Audit Projekt Odense (APO). Audit og Kursus om Urinvejsinfektioner—For Personale og Læger i Almen Praksis Region Syd [Audit and Course on Urinary Tract Infections—For Staff and Doctors in General Practice Region of Southern Denmark]. 2020. Available online: https://findresearcher.sdu.dk/ws/portalfiles/portal/180829459/APO_rapport_UVI_Reg_Syd_2020.pdf (accessed on 3 November 2022).
  32. Audit Projekt Odense (APO). Audit og Kursus om Urinvejsinfektioner—For Personale og Læger i Almen Praksis Region Hovedstaden [Audit and Course on Urinary Tract Infections—For Staff and Doctors in General Practice Capital Region]. 2020. Available online: https://www.apo-danmark.dk/_files/ugd/43637f_e15bf2de049f4d2f8df112ed0dec3fc1.pdf (accessed on 3 November 2022).
Table 1. Levels and standards for eleven quality indicators focusing on the diagnostic process of urinary tract infections in Danish general practice (2020).
Table 1. Levels and standards for eleven quality indicators focusing on the diagnostic process of urinary tract infections in Danish general practice (2020).
Number of and Rationale behind Quality IndicatorsDefinition of Quality Indicators 1Patients 1
(n:n)
Levels (95% CI)
(%)
Standard
(%)
Patients with suspected UTI
QI1: No urinalysis when lack of symptomsPatients a without symptoms b,e who had urinary dipstick and/or microscopy and/or urine culture:Patients a without symptoms b,e475:47699.8 (98.5–100.0)0–10
Patients with lower UTI
QI2: UTI is defined by symptoms and bacteriuria Patients g with ≥one symptom b and a positive urinary dipstick (nitrite and leukocytes) and/or a positive microscopy:Patients g600:121149.5 (42.8–56.3)80–100
QI3: The diagnosis of UTI presupposes symptomsPatients g with ≥one symptom b:Patients g1041:121186.0 (81.4–89.6)90–100
QI4: Urine culture and susceptibility testing when complicated UTIPatients c who had urine culture and susceptibility testing:Patients c301:36283.1 (75.6–88.7)90–100
Patients with pyelonephritis
QI5: Pyelonephritis is defined by symptoms and bacteriuriaPatients f with ≥one symptom e and a positive urinary dipstick (nitrite and leukocytes) and/or a positive microscopy:Patients f8:1650.0 (27.2–72.7)90–100
QI6: Urine culture and susceptibility testing when pyelonephritisPatients d with ≥one symptom e who had urine culture and susceptibility testing:Patients d175:24272.3 (63.9–79.4)80–100
QI7: CRP testing can support the diagnosis of pyelonephritisPatients f examined with a CRP test:Patients f15:1693.8 * (66.1–99.1)80–100
QI8: Often markedly elevated CRP when pyelonephritisPatients f with a CRP test < 20 mg/L:Patients f examined with a CRP test8:15 53.3 (26.7–78.2)0–10
Patients with catheter and UTI
QI9: Other symptoms in catheter users with UTIPatients h with ≥one symptom e:Patients h26:7435.1 (24.5–47.5)90–100
QI10: Urine culture and susceptibility testing for catheter users with UTIPatients h who had urine culture and susceptibility testing:Patients h60:7481.1 (68.8–89.5)90–100
Patients with pregnancy and UTI
QI11: Urine culture and susceptibility testing for pregnant women with UTIPatients i who had urine culture and susceptibility testing:Patients i125:13791.2 * (84.1–95.3)90–100
95% CI = 95% confidence interval. A 95% confidence interval for the corresponding odds was estimated in a logistic regression model using the method of generalised estimating equations to adjust for correlation within practices. UTI = urinary tract infection. Catheter = chronic indwelling urethral or suprapubic catheter. * Within the standard. 1 Presented as numerator:denominator. a Patients with suspected UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI”, “pyelonephritis”, “unresolved” and “other, not UTI”). c Patients diagnosed with complicated lower UTI (the diagnosis: “complicated lower UTI”) including catheter users and pregnant women. d Patients with suspected pyelonephritis (the diagnosis: “pyelonephritis” and “unresolved”). e Symptoms of pyelonephritis: fever, shivering, flank pain, systemically unwell. f Patients diagnosed with pyelonephritis (the diagnosis: “pyelonephritis”). g Patients diagnosed with lower UTI (the diagnosis: “complicated lower UTI” and “uncomplicated lower UTI”). h Catheter users with suspected UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI”, “pyelonephritis” and “unresolved”). I Pregnant women with suspected UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI”, “pyelonephritis” and “unresolved”).
Table 2. Levels and standards for seven quality indicators focusing on the treatment decision for urinary tract infections in Danish general practice (2020).
Table 2. Levels and standards for seven quality indicators focusing on the treatment decision for urinary tract infections in Danish general practice (2020).
Number of and Rationale behind Quality IndicatorsDefinition of Quality Indicators 1Patients 1
(n:n)
Levels (95% CI)
(%)
Standards (%)
Patients with lower UTI
QI12: No antibiotics without urinalysisPatients a not examined with a urinary dipstick or microscopy treated with antibiotics:Patients a not examined with a urinary dipstick or microscopy13:5125.5 (14.7–40.4)0–10
QI13: No antibiotics for patients with low probability of bacteriuriaPatients a with ≥one symptom b and a negative urinary dipstick (nitrite and leukocytes) treated with antibiotics:Patients a with ≥one symptom b and a negative urinary dipstick (nitrite and leukocytes)46:40611.3 (8.4–15.1)0–10
QI14: Wait with antibiotics when inconclusive urinary dipstick Patients a with ≥one symptom b and a urinary dipstick with positive leukocytes but negative nitrite treated with antibiotics:Patients a with ≥one symptom b and a urinary dipstick with positive leukocytes but negative nitrite444:106141.8 (36.1–47.8)0–20
Patients with pyelonephritis
QI15: Antibiotics for patients with pyelonephritisPatients c treated with antibiotics:Patients c13:1492.9 * (62.5–99.0)90–100
Patients with catheter and UTI
QI16: Antibiotics for catheter users with UTIPatients e with ≥one symptom d treated with antibiotics:Patients e with ≥one symptom d11:2642.3 (28.1–58.0)90–100
QI17 2: Change of catheter for catheter users with UTIPatients e with ≥one symptom d and change of catheter:Patients e with ≥one symptom d--90–100
Patients with pregnancy and UTI
QI18: No antibiotics for pregnant women without urinalysisPatients f not examined with a urinary dipstick or microscopy treated with antibiotics:Patients f not examined with a urinary dipstick or microscopy1:425.0 (3.4–76.2)0–10
95% CI = 95% confidence interval. A 95% confidence interval for the corresponding odds was estimated in a logistic regression model using the method of generalised estimating equations to adjust for correlation within practices. UTI = urinary tract infection. Catheter = chronic indwelling urethral or suprapubic catheter. * Within the standard. 1 Presented as numerator:denominator. 2 Data not available, the QI is excluded. a Patients with suspected lower UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI” and “unresolved”). b Symptoms of lower UTI: dysuria, frequency, urgency, new-onset incontinence, suprapubic pain. c Patients diagnosed with pyelonephritis (the diagnosis: “pyelonephritis”) excluding patients referred to hospital. d Symptoms of pyelonephritis: fever, shivering, flank pain, systemically unwell. e Catheter users with suspected UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI”, “pyelonephritis” and “unresolved”) excluding patients referred to hospital. f Pregnant women with suspected UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI”, “pyelonephritis” and “unresolved”).
Table 3. Levels and standards for six quality indicators focusing on the choice of antibiotics prescribed for urinary tract infections in Danish general practice (2020).
Table 3. Levels and standards for six quality indicators focusing on the choice of antibiotics prescribed for urinary tract infections in Danish general practice (2020).
Number of and Rationale behind Quality IndicatorsDefinition of Quality Indicators 1Patients 1
(n:n)
Levels (95% CI)
(%)
Standards (%)
Patients with lower UTI
QI19: Pivmecillinam is first-choice antibiotic for treatment of UTIPatients a with no penicillin allergy treated with pivmecillinam:Patients a with no penicillin allergy treated with antibiotics733:88682.7 (79.2–85.8)90–100
QI20: Ciprofloxacin is not first-choice antibiotic for treatment of lower UTI Patients a treated with ciprofloxacin:Patients a treated with antibiotics10:9061.1 * (0.6–2.0)0–5
Patients with pyelonephritis
QI21: Pivmecillinam is first-choice antibiotic for treatment of pyelonephritisPatients b with no penicillin allergy treated with pivmecillinam:Patients b with no penicillin allergy treated with antibiotics13:1492.9 * (66.1–98.9)90–100
QI22: Ciprofloxacin for treatment of pyelonephritis only if penicillin allergy Patients b with penicillin allergy treated with ciprofloxacin:Patients b treated with ciprofloxacin0:0 -90–100
Patients with catheter and UTI
QI23: Ciprofloxacin is not first-choice antibiotic for treatment of catheter users with UTIPatients c with no penicillin allergy treated with ciprofloxacin:Patients c with no penicillin allergy treated with antibiotics1:234.3 * (0.8–20.7)0–10
Patients with pregnancy and UTI
QI24: Pivmecillinam is first-choice antibiotic for treatment of pregnant women with UTIPatients d with no penicillin allergy treated with pivmecillinam:Patients d with no penicillin allergy treated with antibiotics22:2491.7 * (72.0–97.9)90–100
95% CI = 95% confidence interval. A 95% confidence interval for the corresponding odds was estimated in a logistic regression model using the method of generalised estimating equations to adjust for correlation within practices. UTI = urinary tract infection. Catheter = chronic indwelling urethral or suprapubic catheter. * With 95% possibility within the standard. 1 Presented as numerator:denominator. a Patients with suspected lower UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI” and “unresolved”). b Patients diagnosed with pyelonephritis (the diagnosis: “pyelonephritis”). c Catheter users with suspected UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI”, “pyelonephritis” and “unresolved”). d Pregnant women with suspected UTI (the diagnosis: “complicated lower UTI”, “uncomplicated lower UTI”, “pyelonephritis” and “unresolved”).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Saust, L.T.; Siersma, V.; Lykkegaard, J.; Bjerrum, L.; Hansen, M.P. Diagnosis and Antibiotic Treatment of Urinary Tract Infections in Danish General Practice: A Quality Assessment. Antibiotics 2022, 11, 1759. https://doi.org/10.3390/antibiotics11121759

AMA Style

Saust LT, Siersma V, Lykkegaard J, Bjerrum L, Hansen MP. Diagnosis and Antibiotic Treatment of Urinary Tract Infections in Danish General Practice: A Quality Assessment. Antibiotics. 2022; 11(12):1759. https://doi.org/10.3390/antibiotics11121759

Chicago/Turabian Style

Saust, Laura Trolle, Volkert Siersma, Jesper Lykkegaard, Lars Bjerrum, and Malene Plejdrup Hansen. 2022. "Diagnosis and Antibiotic Treatment of Urinary Tract Infections in Danish General Practice: A Quality Assessment" Antibiotics 11, no. 12: 1759. https://doi.org/10.3390/antibiotics11121759

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop